Wenzhen Zhu

Title: Wenzhen Zhu: Innovator in Medical Compositions for Diabetes Treatment

Introduction

Wenzhen Zhu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical research, particularly in the treatment of type II diabetes. His innovative approach utilizes short interfering RNA (siRNA) technology to develop effective medical compositions.

Latest Patents

Wenzhen Zhu holds a patent for "SiRNA, medical compositions, and methods for treating type II diabetes using the same." This patent describes compositions and methods for treating subjects with type II diabetes. The compositions include a siRNA molecule comprising a sense RNA strand and an anti-sense RNA strand, which form an RNA duplex. The method involves administering a medical composition that reduces uridine 5'-diphospho-glucuronosyltransferase (UGT) levels in the subject. The lengths of the RNA strands range from 15 to 25 nucleotides, and they exhibit 70%-100% complementarity.

Career Highlights

Wenzhen Zhu is affiliated with Peking University, where he conducts his research and development work. His focus on innovative medical solutions has positioned him as a key figure in the field of diabetes treatment. His work is characterized by a commitment to advancing medical science through cutting-edge technology.

Collaborations

Wenzhen Zhu collaborates with notable colleagues, including Liangyi Chen and Yi Wang. These partnerships enhance the research efforts and contribute to the development of effective medical treatments.

Conclusion

Wenzhen Zhu's contributions to medical research, particularly in the treatment of type II diabetes, highlight his innovative spirit and dedication to improving health outcomes. His work with siRNA technology represents a significant advancement in the field.